Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$552K Sell
1,332
-105
-7% -$35.9K 0.17% 113
2026
Q1
$506K Sell
1,437
-351
-20% -$125K 0.18% 110
2025
Q4
$585K Buy
1,788
+487
+37% +$154K 0.19% 103
2025
Q3
$367K Buy
1,301
+234
+22% +$67.9K 0.15% 111
2025
Q2
$298K Buy
1,067
+214
+25% +$60.6K 0.14% 120
2025
Q1
$266K Sell
853
-515
-38% -$152K 0.13% 130
2024
Q4
$357K Buy
+1,368
New +$406K 0.18% 106

Other funds holding AMGN

Argentarii's AMGN Position: Q2 2026 in Review

Argentarii reduced its Amgen (AMGN) stake by 7.3% in Q2 2026, selling an estimated $35.9K and leaving 1,332 shares worth $552K. The position accounts for 0.17% of the portfolio, ranked #113.

Argentarii first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $585K in Q4 2025. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Argentarii held 1,332 shares of Amgen worth $552K as of Q2 2026.
  • Argentarii sold 105 Amgen shares in Q2 2026, an estimated $35.9K.
  • Amgen made up 0.17% of Argentarii's portfolio in Q2 2026, its #113 holding.
  • Argentarii first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Argentarii's Amgen position peaked at $585K in Q4 2025.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Argentarii's 13F filing for Q2 2026, filed 12 Aug 2026.